Ofatumumab

Ofatumumab is a monoclonal antibody used to treat certain types of chronic lymphocytic leukemia (CLL). It works by targeting and helping to destroy cancer cells. It is usually given after other treatments such as chemotherapy or other monoclonal antibody medications have failed. It is given as an intravenous infusion over approximately 2 hours. Side effects may include fever, chills, fatigue, nausea, and rash.

Ofatumumab, commercially available under the brand name Arzerra, is a prescription medication used to treat specific types of blood cancers. Here's a detailed breakdown of its characteristics:

Function:

• Monoclonal antibody: Ofatumumab belongs to a class of drugs known as monoclonal antibodies. These are laboratory-produced proteins designed to target specific structures or cells.
• Targets CD20 protein: Ofatumumab specifically binds to a protein called CD20 present on the surface of certain B-cells, a type of white blood cell involved in the immune system.

Applications:

• Chronic lymphocytic leukemia (CLL): Ofatumumab is primarily indicated for treating CLL, a cancer affecting the white blood cells. It can be used in various treatment scenarios:
  • First-line therapy: For patients with previously untreated CLL.
  • Relapsed or refractory CLL: In cases where the cancer has returned after initial treatment or has not responded adequately to other therapies.
• Follicular lymphoma: This medication is also approved for treating some types of follicular lymphoma, another form of non-Hodgkin lymphoma.

Mechanism of Action:

• Dual action: Ofatumumab works through two primary mechanisms:
  • Direct cell death: Binding to CD20 on cancer cells flags them for destruction by the body's immune system.
  • Immune system activation: It can also stimulate the immune system to more effectively target and eliminate the cancerous B-cells.

Important to Remember:

• Prescription medication: Ofatumumab is a powerful drug and should only be administered under the strict supervision of a qualified healthcare professional in a medical setting.
• Combination therapy: It's often used in combination with other chemotherapy drugs to achieve a more comprehensive therapeutic effect.
• Potential side effects: Like any medication, Ofatumumab can cause various side effects, including:
  • Infusion reactions (fever, chills, headache)
  • Increased risk of infections due to temporary suppression of the immune system
  • Low blood cell counts
  • Fatigue
  • Nausea
  • Diarrhea